124 related articles for article (PubMed ID: 1358351)
1. Resolution of cerebral white matter lesions following long-term penicillamine therapy for Wilson's disease: report of a case.
Huang CC; Chu NS
J Formos Med Assoc; 1992 Jun; 91(6):627-9. PubMed ID: 1358351
[TBL] [Abstract][Full Text] [Related]
2. Wilson's disease: contrast enhancement of cerebral lesions on MR images after penicillamine therapy.
Sener RN
AJR Am J Roentgenol; 1994 Jul; 163(1):228-9. PubMed ID: 8010238
[No Abstract] [Full Text] [Related]
3. Neuropathological findings in penicillamine-treated patients with Wilson's disease.
Horoupian DS; Sternlieb I; Scheinberg IH
Clin Neuropathol; 1988; 7(2):62-7. PubMed ID: 3390974
[TBL] [Abstract][Full Text] [Related]
4. Regression of nodular liver lesions in Wilson's disease.
Kozic D; Svetel M; Petrovic I; Sener RN; Kostic VS
Acta Radiol; 2006 Sep; 47(7):624-7. PubMed ID: 16950693
[TBL] [Abstract][Full Text] [Related]
5. Acute dystonia with thalamic and brainstem lesions after initial penicillamine treatment in Wilson's disease.
Huang CC; Chu NS
Eur Neurol; 1998; 39(1):32-7. PubMed ID: 9476721
[TBL] [Abstract][Full Text] [Related]
6. Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy.
Brewer GJ; Terry CA; Aisen AM; Hill GM
Arch Neurol; 1987 May; 44(5):490-3. PubMed ID: 3579660
[TBL] [Abstract][Full Text] [Related]
7. Systemic sclerosis-like lesions during long-term penicillamine therapy for Wilson's disease.
Miyagawa S; Yoshioka A; Hatoko M; Okuchi T; Sakamoto K
Br J Dermatol; 1987 Jan; 116(1):95-100. PubMed ID: 3814517
[TBL] [Abstract][Full Text] [Related]
8. Partial status epilepticus induced by hypocupremia in a patient with Wilson's disease.
Benbir G; Gunduz A; Ertan S; Ozkara C
Seizure; 2010 Nov; 19(9):602-4. PubMed ID: 20732822
[TBL] [Abstract][Full Text] [Related]
9. Resolution of Wing-Beating Tremor and Magnetic Resonance Imaging Lesions in Wilson's Disease Following Penicillamine.
Brum IV; Parmera JB; Otani RTV; Prates IR; Lucato LT; Cury RG; Barbosa ER
Tremor Other Hyperkinet Mov (N Y); 2024; 14():9. PubMed ID: 38464913
[TBL] [Abstract][Full Text] [Related]
10. [The topography of P300 in neuropsychiatric pharmacotherapy. III. Cognitive P300 fields in an organic psychosyndrome (Wilson's disease) before and during treatment with D-penicillamine].
Maurer K; Ihl R; Dierks T
EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1988 Jun; 19(2):62-4. PubMed ID: 3135996
[TBL] [Abstract][Full Text] [Related]
11. Status epilepticus in Wilson's disease.
Pestana Knight EM; Gilman S; Selwa L
Epileptic Disord; 2009 Jun; 11(2):138-43. PubMed ID: 19473947
[TBL] [Abstract][Full Text] [Related]
12. Recurrent hypokalemic muscle weakness as an initial manifestation of Wilson's disease.
Chu CC; Huang CC; Chu NS
Nephron; 1996; 73(3):477-9. PubMed ID: 8832611
[TBL] [Abstract][Full Text] [Related]
13. Effect of D-penicillamine treatment on brain metabolism in Wilson's disease: a case study.
De Volder A; Sindic CJ; Goffinet AM
J Neurol Neurosurg Psychiatry; 1988 Jul; 51(7):947-9. PubMed ID: 3264567
[TBL] [Abstract][Full Text] [Related]
14. Wilson's disease: a clinico-neuropathological autopsy study.
Meenakshi-Sundaram S; Mahadevan A; Taly AB; Arunodaya GR; Swamy HS; Shankar SK
J Clin Neurosci; 2008 Apr; 15(4):409-17. PubMed ID: 18242093
[TBL] [Abstract][Full Text] [Related]
15. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
[TBL] [Abstract][Full Text] [Related]
16. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.
Hanukoglu A; Curiel B; Berkowitz D; Levine A; Sack J; Lorberboym M
J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823
[TBL] [Abstract][Full Text] [Related]
17. [Cerebral magnetic resonance in Wilson's disease].
Amato C; Bisceglie P; Moschini M
Radiol Med; 1994 Dec; 88(6):752-7. PubMed ID: 7878232
[TBL] [Abstract][Full Text] [Related]
18. Effect of penicillamine and zinc on iron metabolism in Wilson's disease.
Medici V; Di Leo V; Lamboglia F; Bowlus CL; Tseng SC; D'Incà R; Irato P; Burra P; Martines D; Sturniolo GC
Scand J Gastroenterol; 2007 Dec; 42(12):1495-500. PubMed ID: 17994470
[TBL] [Abstract][Full Text] [Related]
19. Clinical, CT and evoked potential manifestations in Wilson's disease with cerebral white matter involvement.
Chu NS
Clin Neurol Neurosurg; 1989; 91(1):45-51. PubMed ID: 2538281
[TBL] [Abstract][Full Text] [Related]
20. Wilson's disease. Development of neurological disease after beginning penicillamine therapy.
Glass JD; Reich SG; DeLong MR
Arch Neurol; 1990 May; 47(5):595-6. PubMed ID: 2334309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
